The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.2043iti3
The Journal of Experimental Medicine, Vol. 204, No. 3, 454-
The Rockefeller University Press, 0022-1007 $30.00
© Bashyam
This Article
Right arrow Full Text (PDF, 1165K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashyam, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bashyam, H.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

IN THIS ISSUE

Switching defects


Figure 1
Activated B cell–like (ABC) lymphomas have a higher rate of intraswitch deletions compared with other lymphomas.

Switching from one antibody isotype to another is a risky business that involves altering and cleaving DNA. B cell lymphomas that are stuck in the riskiest stage suffer repeated mutations and insertions that may further drive oncogenesis, according to Lenz et al. on page 633.

Mature B cells switch from producing IgM to other antibody isotypes during their response to antigen. This process, known as class switch recombination (CSR), is initiated by an enzyme called activation-induced cytidine deaminase (AID). Modification of DNA bases by AID within a so-called switch region leads to DNA cleavage. An intervening sequence is looped out, and two cleaved switch regions are ligated together to create a new gene encoding a new antibody isotype.

The group had previously found that the activated B cell–like (ABC) lymphomas had high expression of AID compared with certain other lymphoma subtypes. They now find that almost two-thirds of the ABC lymphoma cells tested have abnormal CSR events and almost half have internal deletions in a switch region. The switch regions contained as many as 19 independent deletions interspersed with mutations at AID hot spots. The changes could be organized into lineage models, suggesting an ongoing process of aberrant processing.

AID expression is normally a transient phenomenon that occurs as B cells mature. ABC lymphomas, however, are stuck at an intermediate phase of B cell maturation. One consequence is sustained high levels of AID expression. This by itself does not appear to be sufficient to explain the phenotype—another lymphoma subtype expresses almost as much AID but suffers fewer problems with CSR. The AID overexpression in ABC lymphomas may be combined with a defect (as yet hypothetical) in proteins that complete CSR. The frustrated machinery would turn on its own target sites, leading to deletions and mutations rather than a clean class switch.

In one lymphoma, DNA fragments from other chromosomes were inserted into the deletion sites, highlighting the danger inherent in aberrant class switch recombination. Translocations involving cancer-causing genes were also observed, suggesting that defective switching might sometimes further drive oncogenesis in these B cell lymphomas. Formula



Hema Bashyam

hbashyam{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Article

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma
Georg Lenz, Inga Nagel, Reiner Siebert, Anna V. Roschke, Warren Sanger, George W. Wright, Sandeep S. Dave, Bruce Tan, Hong Zhao, Andreas Rosenwald, Hans Konrad Muller-Hermelink, Randy D. Gascoyne, Elias Campo, Elaine S. Jaffe, Erlend B. Smeland, Richard I. Fisher, W. Michael Kuehl, Wing C. Chan, and Louis M. Staudt
J. Exp. Med. 2007 204: 633-643. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 1165K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashyam, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bashyam, H.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS